Considering the special status ofGLUT5 as a fructose-specific transporter and its close relationship with multiplemalignancies ( Table 3), researchers have attemptedto deliver bioactive agents into GLUT5 + malignant cells by using this membraneprotein for the purpose of cancer treatment. The gene discussed is SLC2A5; the disease is cancer.